Selective N-pyrimidinyl pyrroloquinolone PDE5 inhibitors as agents for treatment of male erectile dysfunction.

被引：0

作者：

Jiang, WQ ^{[1
]}

Sui, ZH ^{[1
]}

Guan, JH ^{[1
]}

Macielag, MJ ^{[1
]}

Zhang, SY ^{[1
]}

Qiu, YH ^{[1
]}

Kraft, P ^{[1
]}

Bhattacharjee, S ^{[1
]}

Lombardi, E ^{[1
]}

Haynes-Johnson, D ^{[1
]}

John, TM ^{[1
]}

Clancy, J ^{[1
]}

机构：

[1] Johnson & Johnson PRD, Drug Discovery, Raritan, NJ 08869 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2002年 / 224卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

282-MEDI

引用

页码：U56 / U56

页数：1

共 50 条

[41] Phosphodiesterase Type 5 (PDE5) Inhibitors in Erectile Dysfunction: The Proper Drug for the Proper Patient
Corona, Giovanni
Mondaini, Nicola
Ungar, Andrea
Razzoli, Elisa
Rossi, Andrea
Fusco, Ferdinando
[J]. JOURNAL OF SEXUAL MEDICINE, 2011, 8 (12): : 3418 - 3432
[42] Current safety and tolerability issues in men with erectile dysfunction receiving PDE5 inhibitors
Hellstrom, W. J. G.
[J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (09) : 1547 - 1554
[43] Combining testosterone and PDE5 inhibitors in erectile dysfunction: Basic rationale and clinical evidences
Greco, Emanuela A.
Spera, Giovanni
Aversa, Antonio
[J]. EUROPEAN UROLOGY, 2006, 50 (05) : 940 - 947
[44] SAR development of polycyclic guanine derivatives targeted to the discovery of a selective PDE5 inhibitor for treatment of erectile dysfunction
Pissarnitski, DA
Asberom, T
Boyle, CD
Chackalamannil, S
Chintala, M
Clader, JW
Greenlee, WJ
Hu, YQ
Kurowski, S
Myers, J
Palamanda, J
Stamford, AW
Vemulapalli, S
Wang, YG
Wang, P
Wu, P
Xu, R
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (05) : 1291 - 1294
[45] Design, synthesis and biological evaluation of pyrazolopyrimidinone based potent and selective PDE5 inhibitors for treatment of erectile dysfunction (vol 89, 103022, 2019)
Reddy, G. Lakshma
Dar, Mohd. Ishaq
Hudwekar, Abhinandan D.
Mahajan, Priya
Nargotra, Amit
Baba, Adil Manzoor
Nandi, Utpal
Wazir, Priya
Singh, Gurdarshan
Bharate, Sonali S.
Vishwakarma, Ram A.
Syed, Sajad Hussain
Sawant, Sanghapal D.
[J]. BIOORGANIC CHEMISTRY, 2019, 92
[46] Improving Symptoms in Young Men with Erectile Dysfunction: Testosterone Therapy With or Without PDE5 Inhibitors
Song, J.
Saffati, G.
Naeem, T.
Biles, B.
Pierce, H.
Lipshultz, L., I
Khera, M.
[J]. JOURNAL OF SEXUAL MEDICINE, 2024, 21
[47] Two Birds with One Stone: Regular Use of PDE5 Inhibitors for Treating Male Patients with Erectile Dysfunction and Cardiovascular Diseases
Cai, Zhonglin
Zhang, Jianzhong
Li, Hongjun
[J]. CARDIOVASCULAR DRUGS AND THERAPY, 2019, 33 (01) : 119 - 128
[48] Design and synthesis of selective PDE5 inhibitors for the treatment of MED.
Mathias, JP
Ballard, SA
Beaumont, KC
Bunnage, ME
Wood, A
Street, SDA
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U55 - U55
[49] Two Birds with One Stone: Regular Use of PDE5 Inhibitors for Treating Male Patients with Erectile Dysfunction and Cardiovascular Diseases
Zhonglin Cai
Jianzhong Zhang
Hongjun Li
[J]. Cardiovascular Drugs and Therapy, 2019, 33 : 119 - 128
[50] Should physicians prescribe PDE5 inhibitors to sexually healthy males without erectile dysfunction?
Gruenwald, I
Appel, B.
[J]. EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E702 - U496

← 1 2 3 4 5 →